Search

Your search keyword '"Dietlein, Thomas S."' showing total 135 results
Start Over Author "Dietlein, Thomas S." Search Limiters Peer Reviewed
135 results on '"Dietlein, Thomas S."'

9. Matched case–control comparison of surgical success after XEN45 Gel Stent and PRESERFLO MicroShunt implantation in a Caucasian population.

Author

Lüke, Jan Niklas, Dietlein, Thomas S., Widder, Randolf A., Roessler, Gernot F., Lüke, Vincent, Enders, Philip, Lappa, Alexandra, and Kiessling, David

Subjects
*REOPERATION, *FILTERING surgery, *INTRAOCULAR pressure, *COMPARATIVE method, *TRABECULECTOMY
Abstract

Background: The aim of this study was to compare the outcome of implantation of a XEN45 Gel Stent with the outcome of implantation of a Preserflo MicroShunt in a matched‐pair analysis in eyes being naïve to filtering surgery. Methods: In this comparative, retrospective study, 50 eyes that had undergone XEN45 Gel Stent implantation were compared with 50 eyes after Preserflo implantation. Follow‐up was at least 6 months, and surgical success was measured by criteria A (IOP < 21 mmHg, IOP reduction >20%, no repeat surgery); criteria B (IOP < 18 mmHg, IOP reduction >20%, no repeat surgery); and criteria C (IOP ≤15 mmHg, IOP reduction ≥40%, no repeat surgery). Results: After a follow‐up period of 12 months, mean IOP had decreased from preoperative 25.2 ± 4.8 mmHg in the XEN group to 14.5 ± 4.0 (n = 35) and from 25.3 ± 6.8 mmHg to 11.9 ± 2.9 (n = 41) in the Preserflo group, respectively. The IOP at the last follow‐up of the two groups differed significantly (p < 0.01). The probability of surgical success did not differ concerning Criteria A and B, but surgical success was significantly higher in the Preserflo group for Criteria C (60%, p < 0.01). Conclusion: Both the Preserflo and XEN45 Gel Stent provide an effective and safe treatment option for advanced glaucoma and have a high potential to reduce intraocular pressure. Absolute IOP levels of <16 mmHg after 12 months were significantly more frequent in the Preserflo group. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye.

Author

Kiessling, David, Rennings, Corinna, Hild, Matthias, Lappas, Alexandra, Dietlein, Thomas S., Roessler, Gernot F., and Widder, Randolf A.

Subjects
PHACOEMULSIFICATION, CATARACT surgery, OPHTHALMIC surgery, OPEN-angle glaucoma, INTRAOCULAR pressure
Abstract

Background: To investigate in combined iStent inject implantation with phacoemulsification carried out bilaterally, whether intraocular pressure (IOP)‐lowering effectiveness in the first eye has a predictive potential for the outcome of the second eye in primary open‐angle glaucoma (POAG). Methods: This retrospective study included 72 eyes from 36 participants, who underwent trabecular bypass implantation in combination with cataract surgery at two study centres (Düsseldorf, Cologne). Surgery was classified as either 'success' or 'failure' based on three scores: IOP at follow‐up <21 mmHg (Score A) or IOP < 18 mmHg (Score B), with an IOP reduction >20% respectively, without re‐surgery and IOP ≤ 15 mmHg with an IOP reduction ≥40%, without re‐surgery (Score C). Results: The IOP lowering outcomes of first and second eyes did not differ significantly. There was a significantly higher chance of success in the second eye after effective surgery in the first eye compared with cases after a preceding failure. Within our cohort, a 76% probability of success for the subsequent eye was determined following prior success for Score A. This probability was reduced to 13% if surgery in the first eye failed. The respective probabilities were 75% and 13% for Score B and 40% and 7% for Score C. Conclusions: In bilateral trabecular bypass implantation combined with cataract surgery, there is a high predictive potential for subsequent eyes based on the extent of IOP‐lowering in the initial eye, which should be considered by the surgeon for second eye surgeries. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

29. Revision des PRESERFLO® MicroShunts mit Ologen und Mitomycin C.

Author

Lüke, Jan Niklas, Enders, Philip, Lappa, Alexandra, and Dietlein, Thomas S.

Abstract

Copyright of Die Ophthalmologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results